PRiiMO
PRiiMO41About
PRiiMO is developing an Artificial Intelligence (AI) based platform designed to personalize and optimize the monitoring and treatment of cancer patients. Their goal is to leverage AI to improve patient outcomes and streamline cancer care.
Technology stack
detected 2026-05-24Emailnone
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does PRiiMO do?
PRiiMO is developing an Artificial Intelligence (AI) based platform designed to personalize and optimize the monitoring and treatment of cancer patients. Their goal is to leverage AI to improve patient outcomes and streamline cancer care.
Where is PRiiMO headquartered?
PRiiMO is headquartered in Tel Aviv, Israel.
When was PRiiMO founded?
PRiiMO was founded in 2019.
What industry does PRiiMO operate in?
PRiiMO operates in Healthcare, Patient Support, Cancer, HealthTech, MedTech, AI-Driven Drug Discovery.
How many employees does PRiiMO have?
PRiiMO has approximately 1 people on record.
What is PRiiMO's current status?
PRiiMO's current operating status is: Inactive.
What is PRiiMO's revenue?
StartupHub estimates PRiiMO's annual revenue at $308K (range $174K to $505K, 63% confidence), based on comparable companies in the sector.